EXHIBIT 32.2
                                                                  ------------



                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                            AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly report of K-V Pharmaceutical Company (the
"Company") on Form 10-Q for the quarter ended June 30, 2007, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I,
Ronald J. Kanterman, Vice President and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)   The Report fully complies with the requirements of section
               13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)   The information contained in the Report fairly presents, in all
               material respects, the financial condition and results of
               operations of the Company.



Date: June 25, 2008                          /s/ Ronald J. Kanterman
                                      --------------------------------------
                                                 Ronald J. Kanterman
                                     Vice President and Chief Financial Officer
                                            (Principal Financial Officer)